Search

Author/Creator Seto, Pui

1. COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors. Issue 1 (1st January 2020)

Authors:
Panchal, Anand; Seto, Pui; Wall, Russell; Hillier, Brian J.; Zhu, Ying; Krakow, Jessica; Datt, Aakash; Pongo, Elizabeth; Bagheri, Andisheh; Chen, Tseng-Hui T.; Degenhardt, Jeremiah D.; Culp, Patricia A.; Dettling, Danielle E.; Vinogradova, Maia V.; May, Chad; DuBridge, Robert B.
Journal:
MAbs
Issue:
Volume 12:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors. Issue 1 (1st January 2020)

Authors:
Panchal, Anand; Seto, Pui; Wall, Russell; Hillier, Brian J.; Zhu, Ying; Krakow, Jessica; Datt, Aakash; Pongo, Elizabeth; Bagheri, Andisheh; Chen, Tseng-Hui T.; Degenhardt, Jeremiah D.; Culp, Patricia A.; Dettling, Danielle E.; Vinogradova, Maia V.; May, Chad; DuBridge, Robert B.
Journal:
MAbs
Issue:
Volume 12:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186. Issue 6 (21st June 2022)

Authors:
Dettling, Danielle E; Kwok, Eilene; Quach, Lucy; Datt, Aakash; Degenhardt, Jeremiah D; Panchal, Anand; Seto, Pui; Krakow, Jessica L; Wall, Russell; Hillier, Brian J; Zhu, Ying; Vinogradova, Maia; DuBridge, Robert B; May, Chad
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search